Bibliographic Info
GuidelineGuidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year of Publication2024
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Low
Treatment is recommended for all adolescents (aged ≥12 years) with chronic hepatitis B (CHB) (including pregnant women and girls and women of reproductive age) with HBV DNA >2000 IU/mL and an ALT level above the upper limit of normal (ULN) (30 U/L for boys and 19 U/L for girls). For adolescents, this should be based on ALT>ULN on at least two occasions in a 6- to 12-month period.